CD28: A Protein Involved in Cell Signaling and Immune Response

Target Name: EPPIN

NCBI ID: G57119

EPPIN

CD28: A Protein Involved in Cell Signaling and Immune Response

EPPIN (CT72), also known as CD28, is a protein that is expressed in various tissues throughout the body, including the skin, hair, and lymphoid organs. It is a member of the B-cell maturation antigen (BCMA) family, which includes proteins that are involved in the development and maintenance of B cells, including CD28.

CD28 is a type-I transmembrane protein that consists of an extracellular domain, a transmembrane region, and an intracellular domain. The extracellular domain of CD28 consists of a N-terminus that is involved in protein-protein interactions and is known as the N- terminus transmembrane domain (NTD). The NTD is responsible for the protein's ability to interact with other proteins, which is a crucial function for its function in cell signaling.

The transmembrane region of CD28 is characterized by a hydrophobic cap that helps to stabilize the protein's Membranous structure and prevent it from being targeted by enzymes that could break down the membrane. The intracellular domain of CD28 contains a unique farnesylated cysteine 鈥嬧?媟esidue (Cys-275) that is involved in the protein's stability and functions as a scaffold to recruit other proteins to the membrane.

CD28 is involved in many different processes in the body, including cell signaling, inflammation, and immune responses. One of its well-known functions is its role in the development and maintenance of B cells, which are a type of white blood cell that play a critical role in immune responses. CD28 is involved in the process of B cell activation and proliferation, as well as the regulation of cell survival and apoptosis.

In addition to its role in B cell development and maintenance, CD28 is also involved in the regulation of T cell responses. T cells are a type of immune cell that play a critical role in cell signaling, and CD28 is involved in the regulation of T cell proliferation, differentiation, and survival.

CD28 has also been shown to play a role in cancer progression. Studies have shown that high levels of CD28 are associated with poor prognosis in many types of cancer, including breast, lung, and ovarian cancers. This is because CD28 can promote the growth and survival of cancer cells, as well as inhibit the production of regulatory T cells, which are immune cells that help to maintain the growth and survival of cancer cells.

Despite the many functions of CD28, its role in cell signaling and immune responses is not well understood. Many studies have shown that CD28 plays a critical role in the regulation of cell signaling pathways, including the T cell receptor (TCR) signaling pathway. This is because CD28 is involved in the regulation of the activity of the TCR, which is a protein that plays a critical role in the development and activation of T cells.

In addition to its role in T cell regulation, CD28 has also been shown to play a role in the regulation of B cell development and survival. Studies have shown that CD28 is involved in the regulation of B cell receptor (BCR) signaling, which is the process by which B cells recognize and respond to antigens in the environment.

One of the challenges in studying CD28 is its complex structure and the many different functions that it is involved in. In order to fully understand the functions of CD28, it will be important to continue research into its various roles in cell signaling and immune responses. This will involve the use of techniques such as biochemical assays, cell-based assays, and mass spectrometry to identify the many different functions of CD28 and to determine how it interacts with other proteins.

In conclusion, CD28 is a protein that is involved in many different functions in the body, including cell signaling, inflammation, and immune responses. Its role in the development and maintenance of B cells, as well as its involvement in the regulation of T and B cell responses, makes it an attractive drug target and a potential biomarker for many types of cancer. Further research is needed to fully understand the functions of CD28 and to determine how it can be used to treat

Protein Name: Epididymal Peptidase Inhibitor

The "EPPIN Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EPPIN comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets